Search Results | Cancer Research | American Association for Cancer Research

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3

Masahiro Hiasa, Tatsuo Okui, Yohance M. Allette, Matthew S. Ripsch, Ge-Hong Sun-Wada, Hiroki Wakabayashi, G. David Roodman, Fletcher A. White, Toshiyuki Yoneda

Cancer Res (2017) 77 (6): 1283–1295.

DOI: https://doi.org/10.1158/0008-5472.CAN-15-3545

Published: 14 March 2017

View article

Includes: Supplementary data

Journal Articles

Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma

Jesus Delgado-Calle, Judith Anderson, Meloney D. Cregor, Masahiro Hiasa, John M. Chirgwin, Nadia Carlesso, Toshiyuki Yoneda, Khalid S. Mohammad, Lilian I. Plotkin, G. David Roodman, Teresita Bellido

Cancer Res (2016) 76 (5): 1089–1100.

DOI: https://doi.org/10.1158/0008-5472.CAN-15-1703

Published: 29 February 2016

View article

Includes: Supplementary data

Journal Articles

Bone-Derived IGF Mediates Crosstalk between Bone and Breast Cancer Cells in Bony Metastases

Toru Hiraga, Akira Myoui, Nobuyuki Hashimoto, Akira Sasaki, Kenji Hata, Yoshihiro Morita, Hideki Yoshikawa, Clifford J. Rosen, Gregory R. Mundy, Toshiyuki Yoneda

Cancer Res (2012) 72 (16): 4238–4249.

DOI: https://doi.org/10.1158/0008-5472.CAN-11-3061

Published: 14 August 2012

View article

Includes: Supplementary data

Journal Articles

Hypoxia and Hypoxia-Inducible Factor-1 Expression Enhance Osteolytic Bone Metastases of Breast Cancer

Toru Hiraga, Shinae Kizaka-Kondoh, Kiichi Hirota, Masahiro Hiraoka, Toshiyuki Yoneda

Cancer Res (2007) 67 (9): 4157–4163.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-2355

Published: 04 May 2007

View article

Includes: Supplementary data

Journal Articles

Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain

Diane Palmieri, Julie L. Bronder, Jeanne M. Herring, Toshiyuki Yoneda, Robert J. Weil, Andreas M. Stark, Raffael Kurek, Eleazar Vega-Valle, Lionel Feigenbaum, Douglas Halverson, Alexander O. Vortmeyer, Seth M. Steinberg, Kenneth Aldape, Patricia S. Steeg

Cancer Res (2007) 67 (9): 4190–4198.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-3316

Published: 04 May 2007

View article

Includes: Supplementary data

Journal Articles

Preclinical studies in support of the use of Vorinostat (SAHA) for the treatment of brain metastases of breast cancer

Diane Palmieri, Julie Bronder, Robert Weil, Andreas Stark, Sean Davis, Eleazar Vega-Valle, Jeanne herring, Toshiyuki Yoneda, Raffael Kurek, H. Maximilian Mehdorn, Paul Meltzer, Patricia Steeg

Cancer Res (2007) 67 (9_Supplement): 690.

Published: 01 May 2007

View article

Journal Articles

Identification of therapeutic targets for the treatment of breast cancer brain metastases.

Diane Palmieri, Julie L. Bronder, Robert J. Weil, Andreas Stark, Sean Davis, Toshiyuki Yoneda, H. Maximilian Mehdorn, Paul S. Meltzer, Patricia S. Steeg

Cancer Res (2006) 66 (8_Supplement): 1292.

Published: 15 April 2006

View article

Journal Articles

The contribution of Her-2 to breast cancer brain metastases

Julie L. Bronder, Diane Palmieri, Toshiyuki Yoneda, Robert J. Weil, Andreas M. Stark, H. Maximilian Mehdorn, Sean Davis, Robert Walker, Paul S. Meltzer, Patricia S. Steeg

Cancer Res (2006) 66 (8_Supplement): 290.

Published: 15 April 2006

View article

Journal Articles

Stimulation of Cyclooxygenase-2 Expression by Bone-Derived Transforming Growth Factor-β Enhances Bone Metastases in Breast Cancer

Toru Hiraga, Akira Myoui, Mary E. Choi, Hideki Yoshikawa, Toshiyuki Yoneda

Cancer Res (2006) 66 (4): 2067–2073.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-2012

Published: 17 February 2006

View article

Journal Articles

Identification of therapeutic targets in breast cancer brain metastases.

Julie L. Bronder, Diane Palmieri, Toshiyuki Yoneda, Robert J. Weil, Andreas M. Stark, H. Maximilian Mehdorn, Sean Davis, Paul S. Meltzer, Patricia S. Steeg

Cancer Res (2005) 65 (9_Supplement): 45–46.

Published: 01 May 2005

View article

Journal Articles

Osteopontin promotes bone and non-bone metastases in breast cancer

Akio Hiraki, Nobuyuki Hashimoto, Paul J. Williams, Maria P. Bunegin, Toshiyuki Yoneda

Cancer Res (2005) 65 (9_Supplement): 682.

Published: 01 May 2005

View article

Journal Articles

Establishment of a model for the molecular characterization of brain metastases from primary breast cancer

Julie L. Bronder, Diane Palmieri, Toshiyuki Yoneda, Andreas M. Stark, Robert J. Weil, H. Maximilian Mehdorn, Paul S. Meltzer, Patricia S. Steeg

Cancer Res (2004) 64 (7_Supplement): 182.

Published: 01 April 2004

View article

Journal Articles

Breast cancer metastatic growth inside the blood:brain barrier: Gene expression profiling of brain metastases.

Diane Palmieri, Andreas Stark, Robert Weil, Sean Davis, Maria Merino, Toshiyuki Yoneda, H. Maximilian Mehdornb, Paul Meltzer, Patricia Steeg

Cancer Res (2004) 64 (7_Supplement): 553.

Published: 01 April 2004

View article

Journal Articles

Oral administration of Ki20227, a novel c-Fms tyrosine kinase inhibitor, suppresses osteolytic bone metastasis

Hiroaki Ohno, Kazuo Kubo, Hideko Murooka, Yoshiko Kobayashi, Minako Hirai, Tsuyoshi Nishitoba, Toshiyuki Yoneda, Toshiyuki Isoe

Cancer Res (2004) 64 (7_Supplement): 1072.

Published: 01 April 2004

View article

Journal Articles

C-Src Tyrosine Kinase Activity Is Associated with Tumor Colonization in Bone and Lung in an Animal Model of Human Breast Cancer Metastasis

Akira Myoui, Riko Nishimura, Paul J. Williams, Toru Hiraga, Daisuke Tamura, Toshimi Michigami, Gregory R. Mundy, Toshiyuki Yoneda

Cancer Res (2003) 63 (16): 5028–5033.

Published: 26 August 2003

View article

Journal Articles

Tumor-derived Platelet-derived Growth Factor-BB Plays a Critical Role in Osteosclerotic Bone Metastasis in an Animal Model of Human Breast Cancer

Bing Yi, Paul J. Williams, Marie Niewolna, Yakun Wang, Toshiyuki Yoneda

Cancer Res (2002) 62 (3): 917–923.

Published: 01 February 2002

View article

Journal Articles

The Bisphosphonate Ibandronate Promotes Apoptosis in MDA-MB-231 Human Breast Cancer Cells in Bone Metastases

Toru Hiraga, Paul J. Williams, Gregory R. Mundy, Toshiyuki Yoneda

Cancer Res (2001) 61 (11): 4418–4424.

Published: 01 June 2001

View article

Journal Articles

Therapeutic Efficacy of a Soluble Receptor Activator of Nuclear Factor κB-IgG Fc Fusion Protein in Suppressing Bone Resorption and Hypercalcemia in a Model of Humoral Hypercalcemia of Malignancy

Babatunde O. Oyajobi, Dirk M. Anderson, Kathy Traianedes, Paul J. Williams, Toshiyuki Yoneda, Gregory R. Mundy

Cancer Res (2001) 61 (6): 2572–2578.

Published: 01 March 2001

View article

Journal Articles

E-Cadherin Expression in Human Breast Cancer Cells Suppresses the Development of Osteolytic Bone Metastases in an Experimental Metastasis Model

Gabriel Mbalaviele, Colin R. Dunstan, Akira Sasaki, Paul J. Williams, Gregory R. Mundy, Toshiyuki Yoneda

Cancer Res (1996) 56 (17): 4063–4070.

Published: 01 September 1996

View article

Journal Articles

Bisphosphonate Risedronate Reduces Metastatic Human Breast Cancer Burden in Bone in Nude Mice

Akira Sasaki, Brendan F. Boyce, Beryl Story, Kenneth R. Wright, Mark Chapman, Rogely Boyce, Gregory R. Mundy, Toshiyuki Yoneda

Cancer Res (1995) 55 (16): 3551–3557.

Published: 01 August 1995

View article

NARROW

Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3

Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma

Bone-Derived IGF Mediates Crosstalk between Bone and Breast Cancer Cells in Bony Metastases

Hypoxia and Hypoxia-Inducible Factor-1 Expression Enhance Osteolytic Bone Metastases of Breast Cancer

Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain

Preclinical studies in support of the use of Vorinostat (SAHA) for the treatment of brain metastases of breast cancer

Identification of therapeutic targets for the treatment of breast cancer brain metastases.

The contribution of Her-2 to breast cancer brain metastases

Stimulation of Cyclooxygenase-2 Expression by Bone-Derived Transforming Growth Factor-β Enhances Bone Metastases in Breast Cancer

Identification of therapeutic targets in breast cancer brain metastases.

Osteopontin promotes bone and non-bone metastases in breast cancer

Establishment of a model for the molecular characterization of brain metastases from primary breast cancer

Breast cancer metastatic growth inside the blood:brain barrier: Gene expression profiling of brain metastases.

Oral administration of Ki20227, a novel c-Fms tyrosine kinase inhibitor, suppresses osteolytic bone metastasis

C-Src Tyrosine Kinase Activity Is Associated with Tumor Colonization in Bone and Lung in an Animal Model of Human Breast Cancer Metastasis

Tumor-derived Platelet-derived Growth Factor-BB Plays a Critical Role in Osteosclerotic Bone Metastasis in an Animal Model of Human Breast Cancer

The Bisphosphonate Ibandronate Promotes Apoptosis in MDA-MB-231 Human Breast Cancer Cells in Bone Metastases

Therapeutic Efficacy of a Soluble Receptor Activator of Nuclear Factor κB-IgG Fc Fusion Protein in Suppressing Bone Resorption and Hypercalcemia in a Model of Humoral Hypercalcemia of Malignancy

E-Cadherin Expression in Human Breast Cancer Cells Suppresses the Development of Osteolytic Bone Metastases in an Experimental Metastasis Model

Bisphosphonate Risedronate Reduces Metastatic Human Breast Cancer Burden in Bone in Nude Mice

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only